Analysis	O
of	O
molecular	O
aberrations	O
of	O
Wnt	O
pathway	O
gladiators	O
in	O
colorectal	B-Cancer
cancer	I-Cancer
in	O
the	O
Kashmiri	O
population	O
.	O

The	O
development	O
and	O
progression	O
of	O
colorectal	B-Cancer
cancer	I-Cancer
(	O
CRC	B-Cancer
)	O
is	O
a	O
multi	O
-	O
step	O
process	O
,	O
and	O
the	O
Wnt	O
pathways	O
with	O
its	O
two	O
molecular	O
gladiators	O
adenomatous	O
polyposis	O
coli	O
(	O
APC	O
)	O
and	O
beta	O
-	O
catenin	O
plays	O
an	O
important	O
role	O
in	O
transforming	O
a	O
normal	O
tissue	B-Tissue
into	O
a	O
malignant	B-Cancer
one	I-Cancer
.	O

In	O
this	O
study	O
,	O
we	O
aimed	O
to	O
investigate	O
the	O
role	O
of	O
aberrations	O
in	O
the	O
APC	O
and	O
beta	O
-	O
catenin	O
genes	O
in	O
the	O
pathogenesis	O
of	O
CRC	B-Cancer
in	O
the	O
Kashmir	O
valley	O
,	O
and	O
to	O
correlate	O
it	O
with	O
various	O
clinicopathological	O
variables	O
.	O

We	O
examined	O
the	O
paired	O
tumour	B-Cancer
and	O
normal	O
-	O
tissue	B-Tissue
specimens	I-Tissue
of	O
86	O
CRC	B-Cancer
patients	O
for	O
the	O
occurrence	O
of	O
aberrations	O
in	O
the	O
mutation	O
cluster	O
region	O
(	O
MCR	O
)	O
of	O
the	O
APC	O
gene	O
and	O
exon	O
3	O
of	O
the	O
beta	O
-	O
catenin	O
gene	O
by	O
polymerase	O
chain	O
reaction	O
-	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
(	O
PCR	O
-	O
SSCP	O
)	O
and	O
/	O
or	O
PCR	O
-	O
direct	O
sequencing	O
.	O

Analysis	O
of	O
promoter	O
hypermethylation	O
of	O
the	O
APC	O
gene	O
was	O
also	O
carried	O
out	O
using	O
methylation	O
-	O
specific	O
PCR	O
(	O
MS	O
-	O
PCR	O
)	O
.	O

The	O
overall	O
mutation	O
rate	O
of	O
the	O
MCR	O
of	O
the	O
APC	O
gene	O
among	O
86	O
CRC	B-Cancer
cases	O
was	O
12	O
.	O
8	O
per	O
cent	O
(	O
11	O
of	O
86	O
)	O
.	O

Promoter	O
hypermethylation	O
of	O
APC	O
was	O
observed	O
in	O
54	O
.	O
65	O
per	O
cent	O
(	O
47	O
of	O
86	O
)	O
of	O
cases	O
.	O

Furthermore	O
,	O
we	O
found	O
a	O
significant	O
association	O
between	O
tumour	B-Cancer
location	O
,	O
tumour	B-Cancer
grade	O
and	O
node	B-Multi-tissue_structure
status	O
and	O
the	O
methylation	O
status	O
of	O
the	O
APC	O
gene	O
(	O
p	O
<	O
=	O
0	O
.	O
05	O
)	O
.	O

Although	O
the	O
number	O
of	O
mutations	O
in	O
the	O
APC	O
and	O
beta	O
-	O
catenin	O
genes	O
in	O
our	O
CRC	B-Cancer
cases	O
was	O
very	O
low	O
,	O
the	O
study	O
confirms	O
the	O
role	O
of	O
epigenetic	O
gene	O
silencing	O
of	O
the	O
pivotal	O
molecular	O
gladiator	O
,	O
APC	O
,	O
of	O
the	O
Wnt	O
pathway	O
in	O
the	O
development	O
of	O
CRC	B-Cancer
in	O
the	O
Kashmiri	O
population	O
.	O

